ORIC Pharmaceuticals Inc ORIC

NAS: ORIC | ISIN: US68622P1093 14/11/2024

8,830 USD (-14,02%)

(-14,02%) 14/11/2024

Grafiek ORIC Pharmaceuticals Inc

Grafiek ORIC Pharmaceuticals Inc

1 dag1d -14,02%
1 week1w -13,94%
1 maand1m -7,25%
3 maanden3m -18,47%
6 maanden6m -5,16%
1 jaar1j 35,22%
5 jaar5j -65,74%

ORIC Pharmaceuticals Inc in het nieuws

Toon enkel gratis nieuws

10 maart 2021 · ORIC Pharmaceuticals to Present Posters on Four Programs at the 2021 American Association for Cancer Research (AACR) Annual Meeting · Persbericht

2 maart 2021 · ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences · Persbericht

3 februari 2021 · ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences · Persbericht

11 januari 2021 · ORIC Pharmaceuticals Provides Corporate Update and Highlights Key 2021 Milestones · Persbericht

4 januari 2021 · ORIC Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference · Persbericht

Profiel ORIC Pharmaceuticals Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: oricpharma.com

Hoofdzetel: South San Francisco, California Verenigde Staten

CEO: Jacob Chacko

Werknemers: 86

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe